Navigation Links
Savannah Mayor Otis Johnson Honored as 'Healthy Hero' by The AMERIGROUP Foundation
Date:9/11/2008

Contributions to Support the Ralph Mark Gilbert Civil Rights Museum and

West Broad Street YMCA

VIRGINIA BEACH, Va., Sept. 11 /PRNewswire/ -- The AMERIGROUP Foundation today announced that Savannah, Ga., Mayor Otis Johnson has been honored with its "Healthy Heroes" award. The occasion was celebrated in two ceremonies today at the Savannah City Hall and the Ralph Mark Gilbert Civil Rights Museum.

"AMERIGROUP is pleased to honor those who work tirelessly to make a difference in our communities, and Mayor Johnson certainly fits that description," said Dr. Tunde Sotunde, CEO of AMERIGROUP Community Care in Georgia. "In addition, we are pleased to support the work and mission of both the Ralph Mark Gilbert Civil Rights Museum and the West Broad Street YMCA, the worthy organizations which Mayor Johnson has commended."

The AMERIGROUP Foundation Healthy Heroes Award recognizes leaders, teachers, schools or community based organizations who demonstrate leadership by improving the overall well-being of the community, enhancing health-related initiatives, or serving as advocates for the financially vulnerable or disadvantaged in the area of health promotion or related programs.

To commemorate Mayor Johnson's commitment to the community, the AMERIGROUP Foundation will present a $500 contribution to both the Ralph Mark Gilbert Civil Rights Museum and the West Broad Street YMCA.

"The AMERIGROUP Foundation's commitment and many contributions focused on encouraging healthy families and communities have been a great help to the people of Savannah," Mayor Johnson said. "We are all grateful for their support of local organizations like the Ralph Mark Gilbert Civil Rights Museum and the West Broad Street YMCA that assist and enrich the lives of those in our community."

The Ralph Mark Gilbert Civil Rights Museum, recently honored as "Georgia's Best New History Museum" by the Georgia Journal, is named in honor of
'/>"/>

SOURCE The AMERIGROUP Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Savannahs Memorial Health University Medical Center to Pay U.S. $5.08 Million to Resolve Fraud Allegations
2. Mayor Issues Million Resident Challenge To Educate Central Florida About Blood Pressure
3. Chicago Mayor Richard M. Daley to Address the 7th Annual Compliance and Ethics Institute
4. Brainfood Awarded $25,000 Grant from General Mills Foundation through DC Mayor Fentys New Health Communities Program
5. Mayor Bill White Proclaims World Day of Design in Houston
6. Mayor Bloomberg Declares March 6, 2008 World Glaucoma Day in New York City
7. Mayor Hula Hoops at City Council Meeting
8. AMN Healthcare Chairman Devotes Full Attention to Mayoral Race
9. Congresswoman Norton, Mayor Fenty, Verizon and the Washington Wizards Join the Test for Life Campaign to Encourage HIV Screenings in DC
10. Delray Beach Mayor Commemorates Diagnostic Centers of America (DCA) $2 Million Purchase from Siemens to Become Only Medical Facility in South Florida with Worlds Most Advanced Cardiac Scanner.
11. The United States Conference of Mayors Observes World AIDS Day
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 2RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 3AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Skincare Industry Newcomer Shines 51058 1Skincare Industry Newcomer Shines 51058 2For Treatment of Dyslipidemia Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials 51055 1For Treatment of Dyslipidemia Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials 51055 2For Treatment of Dyslipidemia Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials 51055 3Allied World Schedules Second Quarter 2009 Earnings Announcement and Conference Call 51052 1